Tim’s Take: Most of the wellness industry treats skin aging as a cosmetic issue, completely ignoring the fact that it is actually a systemic, metabolic bottleneck. You can deliver optimal wavelengths from a red light therapy panel directly to the dermis, but if your cells lack the internal metabolic precursors like NAD+ to use that energy, it hits a wall.
In the piece below, Lily Shapiro, PharmD, shifts the conversation from topical illusions to cellular “skinspan” using her CALM framework. While her clinical case for oral nutritional intervention is strong, remember that true longevity requires integrating these internal protocols alongside your rigorous sleep architecture and external recovery tech.
The problem isn’t your products. It’s that the game changed and nobody told you.
I remember sitting in the waiting room of one of the best dermatologists in Manhattan, somewhere around my late thirties, genuinely confused. I had done everything right: a consistent routine, high-end products, access to advice most people never get.
And yet every time I looked closely in the mirror, something was off.
Not dramatically. Just a slow, undeniable drift in texture, in luminosity, in how quickly my skin recovered.
I didn’t understand it yet, but I was experiencing something that happens to almost everyone who takes skincare seriously: the plateau. The moment when doing more of the same stops producing more of the same results.
The plateau isn’t a product failure. It’s a biology shift. And once you understand what actually changes in your skin after your mid-thirties, the whole picture looks different.
The skin you had at 28 and the skin you have now are running on different systems
Skin aging used to be explained mostly as collagen loss. That’s part of it, but it’s an incomplete picture.
What research over the last decade has made increasingly clear is that skin aging is a systems-level event. Several things break down at the same time, in ways that compound each other.
I think about it through four drivers, what I call the CALM framework: Collagen structure, Antioxidant
balance, Lipid barrier integrity, and Mitochondrial function.
These aren’t four separate problems. There are four interconnected systems that regulate how skin builds, protects, and repairs itself.
When mitochondria slow down, cells have less energy to synthesize collagen, and when antioxidant defenses weaken, oxidative stress accelerates barrier degradation.
This is also why hydration stops “holding” the way it used to — when lipid barrier integrity declines, water simply doesn’t stay where it should, regardless of what you apply on top.
The systems talk to each other; targeting one surface symptom at a time misses the conversation entirely. Someone can be using a retinol, a vitamin C, a peptide cream, the whole evidence-backed stack, applied correctly, and still feel the drift.
After 35, the bottleneck isn’t at the surface. It’s deeper. The products haven’t stopped working, the layer they work on has stopped being enough.
I want to be clear: I’m not making the case against topical skincare. Some ingredients genuinely penetrate and have clinical benefit: retinoids remodel collagen, certain peptides signal fibroblasts, and broad-spectrum UV protection prevents cumulative damage.
These matter, and I use them. What topical formulas are largely unable to address, by design, because if they penetrated further, they’d be classified as drugs, is the cellular and metabolic machinery that CALM describes.
They work at the stratum corneum and outward. The mitochondria in your keratinocytes, the oxidative load accumulating in your dermis, the lipid synthesis pathways governing true barrier function: none of that is addressable from the outside in.
After 35, that internal biology becomes the rate-limiting factor. The skin I was trying to fix from the outside had a problem that lived deeper than any cream could reach.
The evidence that changed my thinking
My shift came from my pharmacology training. I was trained to evaluate mechanisms and clinical evidence.
When I applied that lens to skin aging, really interrogating the peer-reviewed literature, it became clear that some of the strongest biological evidence wasn’t in topicals at all. It was oral.
Bioactive collagen peptides have demonstrated dermal bioavailability. Ceramosides™ restore barrier lipid composition from within. Carotenoids and polyphenols measurably reduce UV-induced oxidative damage at the cellular level. NAD+ precursors support mitochondrial function in skin cells.
Each one addresses a different node in the CALM framework, not cosmetically, but structurally. The gap between what the evidence actually supported and what the wellness industry was offering was striking.
And it eventually led me to formulate a product I trusted to take myself, and to build a company around it.
Why skin longevity is a different goal than anti-aging
The word “anti-aging” implies resistance, a war against time. It’s the wrong frame, and I think it’s part of why so many people feel defeated by their skincare even when they’re trying harder than ever.
The more useful frame is longevity. The same way that healthspan, the years you live with full function, is a more meaningful goal than simply living longer, skinspan asks a different question: not how do I look younger, but how do I keep my skin functioning well for as long as possible?
I’m talking about barrier integrity, adequate cellular turnover, mitochondria with enough capacity for repair, and an antioxidant system that isn’t chronically overwhelmed.
When these systems are supported, the cosmetic results tend to follow. Skin that functions well looks like it functions well.
I think about that dermatologist’s waiting room sometimes. I was doing everything I’d been told, I just hadn’t been told about the right layer yet.
If I could go back, I wouldn’t hand myself a new serum, I’d ask a different question: not “what am I putting on my skin?” but “what is my skin actually missing?” The answer, it turned out, was nutritional, not topical.
Lily Shapiro, PharmD, is the founder of ATIKA, an evidence-based skin longevity brand. Prior to ATIKA, she spent 15 years on Wall Street, most recently helping to run a machine learning hedge fund. She holds a PharmD from Northeastern University and an MBA from The Wharton School.
